These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 496920)

  • 1. Relative inability of mother and child to convert phenylalanine of tyrosine--a possible cause of nonspecific mental retardation.
    Fujimoto A; Crawford R; Bessman SP
    Biochem Med; 1979 Jun; 21(3):271-6. PubMed ID: 496920
    [No Abstract]   [Full Text] [Related]  

  • 2. Diet, genetics, and mental retardation interaction between phenylketonuric heterozygous mother and fetus to produce nonspecific diminution of IQ: evidence in support of the justification hypothesis.
    Bessman SP; Williamson ML; Koch R
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1562-6. PubMed ID: 274741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amino acid imbalance as a pathogenetic factor in mental retardation (author's transl)].
    Fekete G
    Klin Wochenschr; 1974 May; 52(6):276-82. PubMed ID: 4408538
    [No Abstract]   [Full Text] [Related]  

  • 4. [Some indices of phenylalanine and tyrosine metabolism in children with phenylketonuria].
    D'iachkova AIa; Lebedev BV
    Vopr Okhr Materin Det; 1969; 14(7):29-32. PubMed ID: 5367726
    [No Abstract]   [Full Text] [Related]  

  • 5. Children of mothers with phenylketonuria.
    Yu JS; O'Halloran MT
    Lancet; 1970 Jan; 1(7640):210-2. PubMed ID: 4189007
    [No Abstract]   [Full Text] [Related]  

  • 6. Glutamine depletion in phenylketonuria. A possible cause of the mental defect.
    Perry TL; Hansen S; Tischler B; Bunting R; Diamond S
    N Engl J Med; 1970 Apr; 282(14):761-6. PubMed ID: 5416968
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenylalanine metabolism and intellectual functioning among carriers of phenylketonuria and hyperphenylalaninaemia.
    Ford RC; Berman JL
    Lancet; 1977 Apr; 1(8015):767-71. PubMed ID: 66568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on conversion of phenylalanine to tyrosine in phenylpyruvic oligophrenia.
    WALLACE HW; MOLDAVE K; MEISTER A
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):632-3. PubMed ID: 13431902
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenylalanine and tyrosine metabolism in phenylketonuria heterozygotes: influence of different phenylalanine hydroxylase mutations.
    Spada M; Dianzani I; Bonetti G; Biondi A; Leone L; Giannattasio S; Ponzone A
    J Inherit Metab Dis; 1998 Jun; 21(3):236-9. PubMed ID: 9686365
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracellular phenylalanine and tyrosine concentrations in 19 heterozygotes for phenylketonuria (PKU) and 26 normals. Do the higher values in heterozygotes explain their lowered intellectual level?
    Thalhammer O; Lubec G; Königshofer H
    Hum Genet; 1979 Jul; 49(3):333-6. PubMed ID: 478540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The offspring of phenylketonuric women.
    Howell RR; Stevenson RE
    Soc Biol; 1971 Sep; 18():S19-29. PubMed ID: 4945474
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-hydroxyindole levels in the blood and CSF in Down's syndrome, phenylketonuria and severe mental retardation.
    Tu J; Partington MW
    Dev Med Child Neurol; 1972 Aug; 14(4):457-66. PubMed ID: 4262081
    [No Abstract]   [Full Text] [Related]  

  • 13. The justification theory: the essential nature of the non-essential amino acids.
    Bessman SP
    Nutr Rev; 1979 Jul; 37(7):209-20. PubMed ID: 384302
    [No Abstract]   [Full Text] [Related]  

  • 14. Mental retardation in four offspring of a hyperphenylalaninemic mother.
    Brown ES; Waisman HA
    Pediatrics; 1971 Sep; 48(3):401-10. PubMed ID: 5094341
    [No Abstract]   [Full Text] [Related]  

  • 15. Injury and insult--considerations of the neuropathological aetiology of mental subnormality.
    Cowie V
    Br J Psychiatry; 1980 Oct; 137():305-12. PubMed ID: 7004555
    [No Abstract]   [Full Text] [Related]  

  • 16. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.
    Smith I; Clayton BE; Wolff OH
    Lancet; 1975 May; 1(7916):1108-11. PubMed ID: 49470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Some experiments on phenylalanine- and tyrosine metabolism in a patient with phenylpyruvic oligophrenia].
    HAMANN I
    Maandschr Kindergeneeskd; 1956 Jan; 24(1):28-36. PubMed ID: 13308279
    [No Abstract]   [Full Text] [Related]  

  • 18. From the Clinical Conference St. Louis Children's Hospital. Phenylketonuria. Diagnostic and therapeutic dilemma.
    Kahn LI
    Clin Pediatr (Phila); 1970 May; 9(5):263-71. PubMed ID: 5445064
    [No Abstract]   [Full Text] [Related]  

  • 19. Causes for high phenylalanine with normal tyrosine in newborn screening programs.
    Berman JL; Cunningham GC; Day RW; Ford R; Hsia DY
    Am J Dis Child; 1969 Jan; 117(1):54-65. PubMed ID: 5782533
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenylketonuria or phenylpyruvic oligophrenia in the rat: behavioural and biochemical correlates.
    Perez VJ
    J Ment Defic Res; 1965 Sep; 9(3):170-82. PubMed ID: 5892858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.